Evotec SE (EVO) Net Income towards Common Stockholders Growth (1y) (2010 - 2025)
Powered by 
Analysis
Evotec SE (EVO) Net Income towards Common Stockholders Growth (1y) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | -9.74% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 34.46% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -101.45% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -29.22% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 96.48% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 22.54% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | 63.65% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | 81.16% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 60.83% |
| Sep 30, 2025 | 15.74% |
| Jun 30, 2025 | 72.09% |
| Mar 31, 2025 | 17.20% |
| Dec 31, 2024 | -147.30% |
| Jun 30, 2024 | -711.12% |
| Dec 31, 2023 | -223.75% |
| Jun 30, 2023 | 53.41% |
| Dec 31, 2022 | 177.07% |
| Sep 30, 2022 | -69.90% |
| Jun 30, 2022 | -141.25% |
| Mar 31, 2022 | -229.31% |
| Dec 31, 2021 | -7,140.17% |
| Sep 30, 2021 | 9,714.16% |
| Dec 31, 2020 | -98.76% |
| Jun 30, 2010 | 112.95% |
| Mar 31, 2010 | -106.22% |